Neoplasia · 2018 · 45 citations · 27 references
MedicineCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingCervical AdenocarcinomaCervical CancerHormonal Cancer TherapyOncogenic Signaling PathwaysSteroid Hormone SignalingClaudin SignalingEstrogen Receptor ExpressionEstrogen Receptor SignalingEstrogen ReceptorsHormone Receptor ModulationMalignant Progression
Cervical adenocarcinomas are believed to lose estrogen response on the basis of no expression of a nuclear estrogen receptor such as ERα in clinical pathology. Here, we demonstrated that cervical adenocarcinoma cells respond to a physiological concentration of estrogen to upregulate claudin-1, a cell surface molecule highly expressed in cervical adenocarcinomas. Knockout of claudin-1 induced apoptosis and significantly inhibited proliferation, migration, and invasion of cervical adenocarcinoma cells and tumorigenicity in vivo. Importantly, all of the cervical adenocarcinoma cell lines examined expressed a membrane-bound type estrogen receptor, G protein-coupled receptor 30 (GPR30/GPER1), but not ERα. Estrogen-dependent induction of claudin-1 expression was mediated by GPR30 via ERK and/or Akt signaling. In surgical specimens, there was a positive correlation between claudin-1 expression and GPR30 expression. Double high expression of claudin-1 and GPR30 predicts poor prognosis in patients with cervical adenocarcinomas. Mechanism-based targeting of estrogen/GPR30 signaling and claudin-1 may be effective for cervical adenocarcinoma therapy.
27
CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites
Yuki Naito, Kimihiro Hino, Hidemasa Bono et al. · Bioinformatics · 2014 · 1.4K citations · Full text
Edward J. Filardo, Jeffrey A. Quinn, A. Raymond Frackelton et al. · Molecular Endocrinology · 2002 · 854 citations · Full text
Lidia Albanito, Antonio Madeo, Rosamaria Lappano et al. · Cancer Research · 2007 · 393 citations · Full text